Back to Geode Capital Management, LLC Geode Capital Management, LLC

HCWB

4 quarters

Position history for Geode Capital Management, LLCGeode Capital Management, LLC's holdings in HCW Biologics Inc.

No. Geode Capital Management exited its HCWB (HCW Biologics) position in Q2 2026. Its Q1 2026 13F listed 35,886 shares worth $12,919. Geode Capital Management first reported HCWB in Q3 2025 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$40,709

Total Shares Change

-11,001

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$4.99
0
2026-Q1
Increased
35,886
+155.7%
$12,9190.0%$2.16
19
2025-Q4
Increased
14,037
+27.6%
$13,6250.0%$5.83
15
2025-Q3
New
11,001
-
$40,7090.0%$22.20
31

Other major holders of HCWB: HRT Financial LP, Vanguard Group Inc., UBS Group AG, Citadel Advisors LLC, Susquehanna International Group, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used